Table 2 Disease-free survival and overall survival
| Â | Arm A IRI+LV+5FU | Arm B LV+5FU | P(log-rank) |
|---|---|---|---|
Disease-free survival (DFS) | Â | Â | 0.436 |
   Progressions, n (%) | 110 (24.9) | 112 (25.9) |  |
   Median (months) | Not reached yet | Not reached yet |  |
   three-year DFS (%) | 78 | 76 |  |
   five-year DFS (%) | 70 | 68 |  |
   seven-year DFS (%) | 66 | 63 |  |
Overall survival (OS) | Â | Â | 0.334 |
   Deaths, n (%) | 118 (26.8) | 128 (29.6) |  |
   Median (months) | Not reached yet | Not reached yet |  |
   three-year OS (%) | 88 | 86 |  |
   five-year OS (%) | 78 | 76 |  |
   seven-year OS (%) | 72 | 69 |  |